Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy in Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07523763
What this trial is testing

Neoadjuvant Low-dose Immunotherapy in Locally Advanced MMR-deficient Colorectal Cancer

Who this might be right for
Colorectal Cancer (MSI-H)Colorectal Cancer (CRC)
Blokhin's Russian Cancer Research Center 30
Testing effectiveness (Phase 2)UnknownNCT00506623
What this trial is testing

Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer

Who this might be right for
Rectal NeoplasmNeoadjuvant Therapy
National Cancer Center, Korea 48
Not applicableEnded earlyNCT05526079
What this trial is testing

Watchful Waiting for Complete Responders to Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer
Henry Ford Health System 15
Testing effectiveness (Phase 2)UnknownNCT03702985
What this trial is testing

Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fudan University 160
Testing effectiveness (Phase 2)Temporarily pausedNCT04558684
What this trial is testing

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

Who this might be right for
Rectal CancerRadiotherapyImmunotherapy+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Not applicableLooking for participantsNCT06761287
What this trial is testing

Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Centre Hospitalier Universitaire Saint Pierre 20
Not applicableActive Not RecruitingNCT06713824
What this trial is testing

Neoadjuvant Radiotherapy Before Surgery for Rectal Cancer, Surgical and Oncological Outcome Analysis, Retrospective Case Control Study in a Single Institute.

Who this might be right for
General SurgeryRadiology
Taichung Veterans General Hospital 1,000
Testing effectiveness (Phase 2)UnknownNCT00967655
What this trial is testing

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

Who this might be right for
Colorectal Cancer
Loma Linda Oncology Medical Group, Inc. 54
Testing effectiveness (Phase 2)Study completedNCT00803647
What this trial is testing

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

Who this might be right for
Metastatic Colorectal Cancer
NSABP Foundation Inc 20
Testing effectiveness (Phase 2)Ended earlyNCT00081224
What this trial is testing

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 3
Not applicableLooking for participantsNCT03874559
What this trial is testing

Exosomes in Rectal Cancer

Who this might be right for
Rectal Cancer
University of Kansas Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06210971
What this trial is testing

Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Hebei Medical University Fourth Hospital 60
Not applicableLooking for participantsNCT06831981
What this trial is testing

Hyperthermia With Chemoradiotherapy in Rectal Cancer

Who this might be right for
Rectal Cancer
University Hospital Tuebingen 264
Testing effectiveness (Phase 2)Looking for participantsNCT07281768
What this trial is testing

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 66
Testing effectiveness (Phase 2)Looking for participantsNCT06162650
What this trial is testing

Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer
National Cheng-Kung University Hospital 42
Not applicableUnknownNCT04745091
What this trial is testing

MRI Split Scar Sign as a Predictor to Complete Pathologic Response After Neoadjuvant Chemoradiation in Rectal Cancer

Who this might be right for
Rectum Cancer
Alexandria University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07104604
What this trial is testing

Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement

Who this might be right for
Rectal Cancer
Affiliated Cancer Hospital of Shantou University Medical College 51
Testing effectiveness (Phase 2)Study completedNCT01481545
What this trial is testing

Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer

Who this might be right for
Rectal Cancer
National Cancer Institute, Naples 62
Not applicableUnknownNCT04598984
What this trial is testing

The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer

Who this might be right for
Rectal Cancer Stage III
Istanbul Training and Research Hospital 60
Not applicableLooking for participantsNCT04103567
What this trial is testing

Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers

Who this might be right for
Rectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 220
Next Page